AAMU
MDCO

Amundi Asset Management US’s Medicines Co MDCO Stock Holding History

Amundi Asset Management US’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-96,362
Closed -$8.19M – 1711
2019
Q4 		$8.19M Sell
96,362
-258,986
-73% -$17.3M 0.01% 793
2019
Q3 		$17.8M Buy
355,348
+43,053
+14% +$1.72M 0.03% 547
2019
Q2 		$11.4M Buy
312,295
+306,195
+5,020% +$10M 0.01% 749
2019
Q1 		$170K Sell
6,100
-900
-13% -$21.2K ﹤0.01% 1464
2018
Q4 		$134 Buy
+7,000
New +$163K ﹤0.01% 1459

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Amundi Asset Management US's MDCO Position: Q1 2020 in Review

Amundi Asset Management US sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 96,362 shares — an estimated $8.19M sold.

Amundi Asset Management US first reported a position in MDCO in Q4 2018 and held it in 5 quarters. The position peaked at $17.8M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Amundi Asset Management US reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 96,362 Medicines Co shares in Q1 2020, an estimated $8.19M.
  • Amundi Asset Management US first reported a position in Medicines Co in Q4 2018 and held it in 5 quarters.
  • Amundi Asset Management US's Medicines Co position peaked at $17.8M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Amundi Asset Management US's 13F filing for Q1 2020, filed 15 May 2020.